Results 171 to 180 of about 219,094 (347)

B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis. [PDF]

open access: yes, 2009
The approach to treating autoimmune disorders is currently undergoing a significant change in focus. As therapies are developed that are more precise in targeting the pathogenesis for these diseases, patients experience significantly fewer side effects ...
Sands, Jacob, Tuscano, Joseph M
core   +2 more sources

Neural Autoantibody Clusters Aid Diagnosis of Cancer

open access: yesClinical Cancer Research, 2014
Purpose: Clustering of neural autoantibodies in patients with paraneoplastic neurologic disorders may predict tumor type. A mathematical analysis of neural autoantibody clusters was performed in 78,889 patients undergoing evaluation for a suspected ...
E. Horta   +7 more
semanticscholar   +1 more source

Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin‐1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic Sclerosis

open access: yesArthritis &Rheumatology, EarlyView.
Objective Systemic sclerosis (SSc) is a rare but severe autoimmune disease characterized by immune dysregulation, fibrosis, and vasculopathy. Although previous studies have highlighted the presence of functional autoantibodies targeting the angiotensin II receptor type 1 (AT1) and endothelin‐1 type A receptor (ETAR), leading to autoantibody‐mediated ...
Wieke M. van Oostveen   +8 more
wiley   +1 more source

Flightless I Alters the Inflammatory Response and Autoantibody Profile in an OVA-Induced Atopic Dermatitis Skin-Like Disease

open access: yesFrontiers in Immunology, 2018
Atopic dermatitis (AD) is a chronic pruritic inflammatory skin disease characterized by excessive inflammation and disrupted skin barrier function. Although the etiology of AD is not completely understood, clinical and basic studies suggest increasing ...
Zlatko Kopecki   +4 more
doaj   +1 more source

A novel autoantibody against moesin in the serum of patients with MPO-ANCA-associated vasculitis.

open access: yesNephrology, Dialysis and Transplantation, 2014
BACKGROUND Antineutrophil cytoplasmic autoantibody (ANCA) directed against myeloperoxidase (MPO), a diagnostic criterion in MPO-ANCA-associated vasculitis (MPO-AAV), does not always correlate with disease activity.
Koya Suzuki   +10 more
semanticscholar   +1 more source

THE THYROID CYTOTOXIC AUTOANTIBODY [PDF]

open access: bronze, 1962
Ian J. Forbes   +3 more
openalex   +1 more source

Serum Type I Interferon Score for Prediction of Clinically Meaningful Disease Progression in Limited Cutaneous Systemic Sclerosis

open access: yesArthritis &Rheumatology, EarlyView.
Objective To assess the value of serum type I interferon (IFN) score in predicting clinically meaningful progression in limited cutaneous systemic sclerosis (lcSSc) using a novel composite endpoint adopted from the MINIMISE clinical trial. Methods A retrospective, longitudinal lcSSc cohort was identified within a national, multicenter observational ...
Stefano Di Donato   +9 more
wiley   +1 more source

Labelling Antibodi Anti-TPO Menggunakan Alkaline Phosphatase (AP) Untuk Deteksi Autoantibodi TPO Pada Serum Pasien Autoimmune Thyroiditis Disease (AITD) Menggunakan Dot-Blot [PDF]

open access: yes, 2013
Autoimmune thyroiditis disease (AITD) is an organ specific autoimmune disorder which commonly found in the world. Presence of Thyroid Peroxidase (TPO) enzyme in AITD patient is often used as biomarker in AITD diseases.
Aulanni'am, Aulanni'am   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy